| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/04/2006 | EP1610772A2 Retinoid replacements and opsin agonists and methods for the use thereof |
| 01/04/2006 | EP1472514A4 Method of preparing delta-9 tetrahydrocannabinol |
| 01/04/2006 | EP1409455B1 Prostaglandin analogues-as ep4 receptor agonists |
| 01/04/2006 | EP1397153A4 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 01/04/2006 | EP1294725B1 Multicyclic compounds and their use as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 01/04/2006 | EP1294390B1 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotection from glutamate toxicity |
| 01/04/2006 | EP1223950B1 Ribozyme therapy for the treatment of proliferative eye diseases |
| 01/04/2006 | EP1149116B1 Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 01/04/2006 | EP0970243B1 Diagnosis and treatment of glaucoma |
| 01/04/2006 | EP0820286B1 Tetrandrine for the treatment for ocular inflammation |
| 01/04/2006 | EP0786990B1 Use of astaxanthin for retarding and ameliorating eye damage |
| 01/04/2006 | CN1715926A Neuregulin mutant, screening method and use |
| 01/04/2006 | CN1714867A Triacetin as a transdermal penetration enhancer |
| 01/04/2006 | CN1714795A Eye drop and its preparing method and use |
| 01/04/2006 | CN1234693C Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 01/04/2006 | CN1234688C 3-arylindole and their use as cb2 receptor agonists |
| 01/04/2006 | CN1234357C Antihypersensitive combination of valsartan and calcium channel blocker |
| 01/03/2006 | US6982270 1-Phenyl-2-oxo-3,4-dihydro-6-phenylaminoquinazoline for example; cytokine suppressive anti-inflammatory drugs; combination therapy |
| 01/03/2006 | US6982265 Pyrrolotriazine inhibitors of kinases |
| 01/03/2006 | US6982253 Liquid formulation of decitabine and use of the same |
| 01/03/2006 | US6982079 Administering to eye drug with vasoconstriction and carrier |
| 01/03/2006 | CA2243824C Therapeutic agent for keratoconjunctiva diseases |
| 12/29/2005 | WO2003033671A3 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 12/29/2005 | WO2003012122A3 Crystallized structure of type iv collagen nc1 domain hexamer |
| 12/29/2005 | US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 12/29/2005 | US20050288501 Reducing a 2-(protected amino)-3-(piperazin-1-yl, N-morpholinyl, or N-thiomorpholinyl) propanoate, deprotecting the amine, and reacting with t-butylisothiocyanate |
| 12/29/2005 | US20050288376 Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides |
| 12/29/2005 | US20050288366 Administering N-(4-carboxybutyl)-N-(p-carboxybenzyl)-benzyl- or phenethyl-amine derivatives: 4-({(4-Carboxybutyl)[3-(4-cyclohexylphenoxy)benzyl]amino}methyl)-benzoic acid; stimulate soluble guanylate cyclase also via a novel mechanism of action which takes place without involvement of the heme group |
| 12/29/2005 | US20050288357 e.g. 4-(2-{2-[4-hydroxy-4-(1-propylcyclobutyl)but-1-enyl]-5-oxopyrrolidin-1-yl}ethyl)benzoic acid; antiinflammatory, hypotensive, antiulcer agent |
| 12/29/2005 | US20050288356 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 12/29/2005 | US20050288353 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 12/29/2005 | US20050288337 Novel compounds |
| 12/29/2005 | US20050288305 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 12/29/2005 | US20050288303 Cyclic protein tyrosine kinase inhibitors |
| 12/29/2005 | US20050288274 Treating rhinitis by topically administering an epinastine solution to the nasal mucous membrane |
| 12/29/2005 | US20050288262 such as 3,10-Dibenzyloxyminocycline, used to treat bacterial infections and neoplasms, as well as blocking tetracycline efflux and modulation of gene expression |
| 12/29/2005 | US20050288237 Novel derivative of flavone c-glycoside and composition containing the same |
| 12/29/2005 | US20050287605 Caspase 3 inhibitors |
| 12/29/2005 | US20050287546 Novel proteases |
| 12/29/2005 | DE19748040B4 Carbonsäurederivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate, die diese Verbindungen enthalten Carboxylic acid derivatives, processes for their preparation and pharmaceutical preparations containing these compounds |
| 12/28/2005 | EP1609803A1 Modified antibody against cd22 and utilization thereof |
| 12/28/2005 | EP1609468A2 A composition on the basis of a sulfur-containing antioxidant and its use for the manufacture of a medicament for treating mucositis |
| 12/28/2005 | EP1609465A1 Ophthalmic drug delivery system using polymer micell |
| 12/28/2005 | EP1608365A1 Method for treating vascular hyperpermeable disease |
| 12/28/2005 | EP1608363A1 Methods for treating inflammatory conditions or inhibiting jnk |
| 12/28/2005 | EP1461318B9 Tetrahydroquinoline analogues as muscarinic agonists |
| 12/28/2005 | EP1377593B1 2-amino-propanol derivatives |
| 12/28/2005 | EP1365757B1 Use of xylyloxy alkyl amines for treating tinnitus |
| 12/28/2005 | EP1246627B1 Polyanhydrides with biologically active degradation products |
| 12/28/2005 | EP1223170B1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof |
| 12/28/2005 | EP0971959B1 Humanized antibodies and methods for forming humanized antibodies |
| 12/28/2005 | EP0920315B1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists |
| 12/28/2005 | CN1714096A Mmp inhibitors |
| 12/28/2005 | CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 12/28/2005 | CN1233643C Ramification of a compound of medication as well as preparation method and application |
| 12/28/2005 | CN1233360C Chinese medicine preparation for treating hemorrhage of the ocular fundus vitreous opacity |
| 12/28/2005 | CN1233324C Use of composition of intraocular pressure reducing agent |
| 12/28/2005 | CA2510960A1 Method for preparing therapeutic ophthalmic articles using compressed fluids |
| 12/27/2005 | US6979747 Antioxidants, preparation processes and their uses |
| 12/27/2005 | US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology |
| 12/27/2005 | US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 12/27/2005 | US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 12/27/2005 | CA2160712C Novel 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents |
| 12/22/2005 | US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 12/22/2005 | US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/22/2005 | US20050282872 Novel thyroid receptor ligands and method II |
| 12/22/2005 | US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis |
| 12/22/2005 | US20050282798 Pharmaceutical compounds |
| 12/22/2005 | US20050282769 Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage |
| 12/22/2005 | US20050281818 Method for the treatment of fibrosis |
| 12/22/2005 | US20050279350 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 12/21/2005 | EP1606625A1 Use of substances inhibiting the association of smad protein with ubiquitin c-terminal hydrolase for altering cellular responses to tgf-beta or bmp |
| 12/21/2005 | EP1606301A2 Aptamer therapeutics useful in ocular pharmacotherapy |
| 12/21/2005 | EP1605847A2 Antibody-targeted photodynamic therapy |
| 12/21/2005 | EP1429780B1 Method of treating middle ear infections |
| 12/21/2005 | EP1389205B1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 12/21/2005 | EP1379547B1 Modified cyclosporin as a pro-drug and use thereof as a medicament |
| 12/21/2005 | EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 12/21/2005 | EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors |
| 12/21/2005 | CN1711107A Remedy for glaucoma comprising Rho kinase inhibitor and beta-blocker |
| 12/21/2005 | CN1711092A The use of an anti-allergy agent and a steroid to treat allergic rhinitis |
| 12/21/2005 | CN1232623C Method for moistening contact lens and low ionic strength ophthalmic compositions used therefor |
| 12/21/2005 | CN1232520C Salts of bicyclic N-acylated imidazo-3-amines and imidazo-5-amines |
| 12/21/2005 | CN1232305C Aseptics |
| 12/21/2005 | CN1232265C Liquid for moist of eyes and its preparation method |
| 12/20/2005 | US6977268 Diacid isoindoleine amide derivative |
| 12/20/2005 | US6977267 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 12/20/2005 | US6977263 Chemical compounds |
| 12/20/2005 | US6977246 Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency |
| 12/20/2005 | CA2329703C Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 12/20/2005 | CA2181569C Ep2-receptor agonists as agents for lowering intraocular pressure |
| 12/15/2005 | WO2005118582A1 Corneal perception recovery drug containing amide compound |
| 12/15/2005 | WO2005118543A1 Kinase inhibitor and use thereof |
| 12/15/2005 | WO2005117988A1 Antibody colour pigment conjugates for changing eye color appearance |
| 12/15/2005 | WO2005117987A1 Antibody conjugates targeting to ocular proteins |
| 12/15/2005 | WO2003062370A3 Multimeric proteins and methods of making and using same |
| 12/15/2005 | US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function |
| 12/15/2005 | US20050277627 Colchinol derivatives as vascular damaging agents |
| 12/15/2005 | US20050276820 structural modification alters the biological persistence, preferably the biological half-life |
| 12/15/2005 | CA2568524A1 Modulators of muscarinic receptors |